Sermonix has assembled a deep bench of talent within the women’s healthcare and oncology clinical development and commercialization arena.
David Portman, MD: CEO and Chief Medical Officer
James Symons, MS, PhD: VP of Clinical Development
Elizabeth Attias, ScD: VP of Business Development
Miriam Portman, MD: Chief Operating Officer
Paul Plourde, MD: VP, Oncology Clinical Development
Anthony H. Wild, Ph.D: Non-Executive Chairman of the Board
Barry Komm, Ph.D: Chief Scientific Officer